Stackelberg Evolutionary Games of Cancer Treatment

What Treatment Strategy to Choose if Cancer Can be Stabilized?

Journal Article (2024)
Author(s)

Monica Salvioli (TU Delft - Technology, Policy and Management, Maastricht University)

Hasti Garjani (TU Delft - Electrical Engineering, Mathematics and Computer Science)

Mohammadreza Satouri (TU Delft - Technology, Policy and Management)

Mark Broom (City University London)

Yannick Viossat (Université Paris-Dauphine)

Joel S. Brown (Lee Moffitt Cancer Center and Research Institute)

Johan Dubbeldam (TU Delft - Electrical Engineering, Mathematics and Computer Science)

Kateřina Staňková (TU Delft - Technology, Policy and Management)

Research Group
Mathematical Physics
DOI related publication
https://doi.org/10.1007/s13235-024-00609-z Final published version
More Info
expand_more
Publication Year
2024
Language
English
Research Group
Mathematical Physics
Journal title
Dynamic Games and Applications
Issue number
5
Volume number
15
Pages (from-to)
1750-1769
Downloads counter
140
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

We present a game-theoretic model of a polymorphic cancer cell population where the treatment-induced resistance is a quantitative evolving trait. When stabilization of the tumor burden is possible, we expand the model into a Stackelberg evolutionary game, where the physician is the leader and the cancer cells are followers. The physician chooses a treatment dose to maximize an objective function that is a proxy of the patient’s quality of life. In response, the cancer cells evolve a resistance level that maximizes their proliferation and survival. Assuming that cancer is in its ecological equilibrium, we compare the outcomes of three different treatment strategies: giving the maximum tolerable dose throughout, corresponding to the standard of care for most metastatic cancers, an ecologically enlightened therapy, where the physician anticipates the short-run, ecological response of cancer cells to their treatment, but not the evolution of resistance to treatment, and an evolutionarily enlightened therapy, where the physician anticipates both ecological and evolutionary consequences of the treatment. Of the three therapeutic strategies, the evolutionarily enlightened therapy leads to the highest values of the objective function, the lowest treatment dose, and the lowest treatment-induced resistance. Conversely, in our model, the maximum tolerable dose leads to the worst values of the objective function, the highest treatment dose, and the highest treatment-induced resistance.